MetLife Investment Management’s InnovAge Holding INNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$97.8K Buy
+12,189
New +$91K ﹤0.01% 2555
2023
Q4
Sell
-10,873
Closed -$65.1K 2846
2023
Q3
$65.1K Hold
10,873
﹤0.01% 2785
2023
Q2
$81.5K Buy
+10,873
New +$74.6K ﹤0.01% 2800
2023
Q1
Sell
-11,572
Closed -$83.1K 2805
2022
Q4
$83.1K Buy
+11,572
New +$74.3K ﹤0.01% 2661
2021
Q4
Sell
-8,476
Closed -$56K 2525
2021
Q3
$56K Hold
8,476
﹤0.01% 2522
2021
Q2
$181K Buy
+8,476
New +$194K ﹤0.01% 2230

Other funds holding INNV

MetLife Investment Management's INNV Position: Q1 2026 in Review

MetLife Investment Management opened a new position in InnovAge Holding (INNV) in Q1 2026: 12,189 shares worth $97.8K. The stake represents ﹤0.01% of the portfolio and ranks #2555 among its holdings. This is a return to the name: MetLife Investment Management previously reported a position in INNV as recently as Q3 2023.

MetLife Investment Management first reported a position in INNV in Q2 2021 and has held it in 6 quarters since. The position peaked at $181K in Q2 2021. 103 funds tracked by Wall St. Rank hold INNV as of Q1 2026.

  • MetLife Investment Management held 12,189 shares of InnovAge Holding worth $97.8K as of Q1 2026.
  • InnovAge Holding was a new MetLife Investment Management position in Q1 2026.
  • InnovAge Holding made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2555 holding.
  • MetLife Investment Management first reported a position in InnovAge Holding in Q2 2021 and has held it in 6 quarters since.
  • MetLife Investment Management's InnovAge Holding position peaked at $181K in Q2 2021.
  • 103 funds tracked by Wall St. Rank held InnovAge Holding as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.